Home  |  Contact

UniProtKB/Swiss-Prot Q02978: Variant p.Glu141Lys

Mitochondrial 2-oxoglutarate/malate carrier protein
Gene: SLC25A11
Variant information

Variant position:  141
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  LP/P [Disclaimer]
The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change:  From Glutamate (E) to Lysine (K) at position 141 (E141K, p.Glu141Lys).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from medium size and acidic (E) to large size and basic (K)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  1
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description:  In PGL6; loss of protein expression.
Any additional useful information about the variant.

Other resources:  
Links to websites of interest for the variant.



Sequence information

Variant position:  141
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  314
The length of the canonical sequence.

Location on the sequence:   LKAVIGMTAGATGAFVGTPA  E VALIRMTADGRLPADQRRGY
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         LKAVIGMTAGATGAFVGTPAEVALIRMTADGRLPADQRRGY

Mouse                         LKALIGMTAGATGAFVGTPAEVALIRMTADGRLPADQRRGY

Rat                           LKALIGMTAGATGAFVGPPAEVALIRMTADGRLPADQRRGY

Bovine                        LKAVIGMTAGATGAFVGTPAEVALIRMTADGRLPVDQRRGY

Caenorhabditis elegans        MKAVLGMTAGGIGSFVGTPAEIALIRMTGDGRLPVEQRRNY

Slime mold                    QKIMVGMLSGAGGAIVGTPADLTMVRMQADGKLPFNLRRNY

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 2 – 314 Mitochondrial 2-oxoglutarate/malate carrier protein
Repeat 117 – 208 Solcar 2


Literature citations

Germline Mutations in the Mitochondrial 2-Oxoglutarate/Malate Carrier SLC25A11 Gene Confer a Predisposition to Metastatic Paragangliomas.
Buffet A.; Morin A.; Castro-Vega L.J.; Habarou F.; Lussey-Lepoutre C.; Letouze E.; Lefebvre H.; Guilhem I.; Haissaguerre M.; Raingeard I.; Padilla-Girola M.; Tran T.; Tchara L.; Bertherat J.; Amar L.; Ottolenghi C.; Burnichon N.; Gimenez-Roqueplo A.P.; Favier J.;
Cancer Res. 78:1914-1922(2018)
Cited for: INVOLVEMENT IN PGL6; VARIANTS PGL6 LYS-141; VAL-147 AND THR-239; CHARACTERIZATION OF VARIANTS PGL6 LYS-141; VAL-147 AND THR-239; FUNCTION;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.